MyAverix Finance
SHE · Healthcare
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211)
Drug Manufacturers - Specialty & Generic
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $5.04B, P/E ratio is 134.11, net margin is 8.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 301211
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) — FAQ
What is Hubei Biocause Heilen Pharmaceutical Co. Ltd.'s market cap?
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a reported market cap of $5.04B (data as of 2026-03-29).
What is 301211's P/E ratio?
The price-to-earnings (P/E) ratio for Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) is 134.11 (data as of 2026-03-29).
Does Hubei Biocause Heilen Pharmaceutical Co. Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211). Check the MyAverix Finance app for the latest dividend data.
What sector is Hubei Biocause Heilen Pharmaceutical Co. Ltd. in?
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 301211 listed on?
301211 is listed on SHE.
What is Hubei Biocause Heilen Pharmaceutical Co. Ltd.'s net margin?
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) reports a net margin of 8.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.